Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Peglast 6 mg Injection
Manufacturer/Marketed By : Zuventus Healthcare Ltd
$72.53 $27.20
Sidmex Inovia offers bulk export supply of Peglast 6 mg Injection (Pegfilgrastim 6 mg) for hospitals, distributors and tender buyers. Request a quote with your quantity and destination country.Documents, cold-chain...
Pegfilgrastim 6 mg
Active Pharmaceutical Ingredient
Peglast 6 mg Injection
$72.53
$27.20
Sidmex Inovia offers bulk export supply of Peglast 6 mg Injection (Pegfilgrastim 6 mg) for hospitals, distributors and tender buyers. Request a quote with your quantity and destination country.
Documents, cold-chain shipping and tenders: see our Export FAQ.
Priority markets: United Arab Emirates, Brazil, Turkey, Singapore, Kenya, Somalia, Ghana, Saudi Arabia, Mauritius, Nigeria, Tanzania, Senegal, Democratic Republic of the Congo, Mali. We also export worldwide, including:
Middle East: Oman, Qatar, Kuwait, Bahrain, Iraq, Jordan, Lebanon, Yemen, Iran
Africa: Egypt, Algeria, Morocco, Libya, Burkina Faso, Côte d'Ivoire, Gambia, Rwanda, Ethiopia, Djibouti, South Africa, Zimbabwe
Asia: Sri Lanka, Bangladesh, Nepal, Maldives, Philippines, Vietnam, Laos, Malaysia, Thailand, Taiwan
CIS & Eastern Europe: Russia, Kazakhstan, Uzbekistan, Azerbaijan, Georgia, Serbia, Latvia, Tajikistan
Latin America & Caribbean: Mexico, Chile, Peru, Colombia, Bolivia, Venezuela
Europe & Other: Switzerland, United Kingdom, Canada
Related products we supply: Alburel 20 gm/100 ml Injection
Peglast 6 mg Injection is a vital prescription medication designed to reduce the risk of infections following cancer treatments. This innovative therapy enhances the production of white blood cells in your body, which are essential for maintaining a robust immune response and warding off infections. In addition to its primary use in cancer patients, Peglast may also assist individuals recovering from exposure to high doses of radiation, promoting quicker recovery and overall health. It's important to note that while Peglast is effective, patients should discuss any existing health conditions or medications with their healthcare provider to avoid potential interactions. This injection is typically administered under medical supervision, ensuring that any side effects are monitored closely. If you are undergoing cancer treatment or have faced significant radiation exposure, consult your doctor to see if Peglast 6 mg Injection is a suitable option for your recovery plan. With its ability to support immune function, Peglast plays a crucial role in the journey towards better health after challenging medical treatments.
Active Pharmaceutical Ingredient
Uses
• Peglast 6 mg injection is primarily used to prevent infections in patients undergoing chemotherapy. Chemotherapy can weaken the immune system, making individuals more susceptible to infections. By administering Peglast 6 mg injection, healthcare providers can help bolster the immune response during this vulnerable period. This allows patients to continue their cancer treatment with reduced risk of infection-related complications.
• In addition to infection prevention, Peglast 6 mg injection supports the recovery of white blood cells following chemotherapy sessions. A decrease in white blood cell count is a common side effect of chemotherapy, which can lead to increased risk of serious infections. The use of Peglast 6 mg injection helps stimulate the production of these essential immune cells, aiding patients in maintaining their overall health during treatment. This is particularly important for those undergoing multiple rounds of chemotherapy.
• Peglast 6 mg injection is often administered as part of a comprehensive treatment plan for cancer patients. It is especially beneficial for individuals who are at a higher risk of febrile neutropenia due to their treatment regimen. By incorporating Peglast 6 mg injection into their care, patients can enhance their resilience against infections and improve their quality of life during chemotherapy. This proactive approach helps ensure that treatment can proceed without significant delays caused by infection.
• For patients receiving aggressive chemotherapy, Peglast 6 mg injection serves as a critical tool in managing their health. The injection is designed to minimize the incidence of infections, which can complicate recovery. By providing this supportive care, Peglast 6 mg injection allows patients to better tolerate their treatment and focus on their recovery journey. This is particularly vital for those who may have other underlying health concerns that could complicate their cancer treatment.
Benefits
Peglast 6 mg works by stimulating your body's immune system to increase the production of white blood cells. The cells that help us fight infections are called white blood cells. You must use this medicine under medical supervision to make it really effective. To help prevent infections, avoid being in crowded places and wash your hands often. Drink plenty of fluids, unless you are told otherwise by your doctor or health care professional.
Side Effects
Peglast 6 mg Injection adverse effects can vary depending on various factors. Some of the common and severe adverse effects are listed below.
Most Common Side Effects
• Dizziness
• Headache
• Appetite Loss
• Constipation
• Infection in the Urinary and Respiratory Tract
• Hair Loss
• Low Count of Red Blood cells
• Fluctuation in the Blood Pressure
• Diarrhoea
• Dizziness
• Nose Bleeds
• Tingling in Feet and hands
• Chest Pain
• Pain during Urination
Common Side Effects
• Rashes
• Headache
• Nausea
• Bone pain
• Leg pain
How To Use
Peglast Injection is given through intravenous infusion by your doctor or nurse. Follow the guidelines of the doctor carefully during the treatment. Please do not self-administer this Peglast 6 mg.
Safety Advice
• Alcohol: It is not known whether it is safe to drink alcohol with Peglast Injection. Consult your medical doctor for advice.
• Kidney: Peglast 6 mg Injection is safe to use in patients with kidney disease. No dose change is recommended in patients with kidney impairment, including those with end-stage kidney disease.
• Breastfeeding: Peglast 6 mg Injection should not be given to lactating women. There is no clinical experience with nursing women.
• Liver: There is only a limited amount of information available on the use of Peglast 6 mg Injection in patients with liver disease. Consult your medical doctor for advice.
• Pregnancy: Peglast 6 mg Injection is not recommended during pregnancy or in women who may become pregnant and are not using contraceptives. There are no data available on the use of Peglast 6 mg Injection in pregnant women. Studies in animals have shown toxicity to the reproductive system. The potential risk to the human embryo or fetus is not known.
• Driving: Peglast 6 mg has no or negligible effects on the ability to drive or to use machines.
Disclaimer
Sidmex Inovia strives to provide accurate and reliable information; however, all content on this website, including product descriptions and compositions, is for informational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment.
Users are advised to consult a qualified healthcare professional before making any medical decisions. The information provided should not be used for self-diagnosis or self-medication.
All products listed are intended strictly for B2B and bulk inquiry purposes only. Sidmex Inovia does not promote direct consumer use and aims to support, not replace, the healthcare professional–patient relationship.
Product names, trademarks, and brands belong to their respective owners, and their use does not imply any affiliation or endorsement. Sidmex Inovia shall not be held responsible for any consequences arising from the use of the information provided on this website.